JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle rad51'

Search results for: 'research area cell cycle rad51'

A3825 SLx-2119

1 Citation

Target: ROCK

Summary: Selective ROCK2 inhibitor

≥22.65 mg/mL
A3008 Y-27632 dihydrochloride

19 Citation

Target: ROCK

Summary: ROCK1 inhibitor

≥111.2 mg/mL
A1723 Roscovitine (Seliciclib,CYC202)

2 Citation

Summary: CDK inhibitor,potent and selective

insoluble in H2O; ≥17.72 mg/mL
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A3197 AT7519 Hydrochloride

Target: Cyclin-Dependent Kinases

Summary: Multi-CDK inhibitor

≥29.93 mg/mL
A2521 VE-821

2 Citation

Summary: ATR kinase inhibitor

≥62.5 mg/mL
A8336 KU-60019

2 Citation

Target: ATM/ATR

Summary: ATM kinase inhibitor,potent and selective

≥27.4 mg/mL
A8624 CGK733

Target: ATM/ATR

Summary: ATM/ATR inhibitor,potent and selective

≥27.8 mg/mL
A8625 CP-466722

Target: ATM

Summary: ATM inhibitor,potent and reversible

≥4.36 mg/mL
A4395 10-DAB (10-Deacetylbaccatin)

Summary: Precursor of antitumor compound Palitaxel and Docetaxel

≥22.25 mg/mL